Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the bronchodilatory efficacy of NVA237 in patients with stable COPD in terms of through FEV1 (mean of 23h 15 min & 23h 45 min post dose) following 7 days of treatment, by comparing four doses of NVA237 (12.5, 25, 50 &100 micrograms o.d.) with placebo delivered by the single Dose Dry Powder Inhaler (SDDPI).
Inclusion criteria
- Chronic Obstructive Pulmonary Disease (COPD)